273
Views
31
CrossRef citations to date
0
Altmetric
Case Report

Fusarium osteomyelitis: Case report and review of the literature

, , &
Pages 237-240 | Received 10 Dec 2004, Accepted 23 Dec 2004, Published online: 08 Jul 2009

References

  • Nucci M, Anaissie E. Cutaneous infection by Fusarium species in healthy and immunocompromized hosts: implications for diagnosis and management. Clin Infect Dis 2002; 35:909–20.
  • Cho CT, Vats TS, Lowman JT, Brandsberg JW, Tosh FE. Fusarium solani infection during treatment for acute leukemia. J Pediatr 1973;83:1028–31.
  • Boutati EI, Anaisse EJ. Fusarium, a significant emerging pathogen in patients with hematologic malignancy: 10 y experience at a cancer center and implications for management. Blood 1997;90:999–1008.
  • Mandell GL, Bennett JE, Dolin R. Principles and Practice of Infectious Disease. Fifth Edition 2000;1:2774–5.
  • Bourguignon RL, Walsh AF, Flynn JC, Baro C, Spinos E. Fusarium species osteomyelitis. Case report. J Bone Joint Surg Am 1976;58:722–3.
  • Page JC, Friedlander G, Dockery GL. Postoperative Fusarium osteomyelitis. J Foot Surg 1982;21:174–6.
  • Nuovo MA, Simmonds JE, Chacho MS, McKitrick JC. Fusarium solani osteomyelitis with probable nosocomial spread. Am J Clin Pathol 1988;90:738–41.
  • Brint JM, Flynn PM, Pearson TA, Pui C. Disseminated fusariosis involving bone in an adolescent with leukemia. Pediatr Infect Dis J 1992;11:965–8.
  • Bader M, Jafri AK, Kruegar T, Kumar V. Fusarium osteomyelitis of the foot in a patient with diabetes mellitus. Scand J Infect Dis 2003;35:895–6.
  • Martino P, Gastalsi R, Raccah R, Girmenia C. Clinical patterns of Fusarium infections in immunocompromized patients. J Infect 1994;28(Suppl):7–15.
  • Perfect JR, Marr KA, Walsh TJ, Greenberg RN, DuPont B, de la Torre-Cisneros J, et al. Voriconazole treatment for less-common, emerging, or refractory fungal infections. Clin Infect Dis 2003;36:1122–31.
  • Consigny S, Dhedin N, Datry A, Choquet S, Leblond V, Chosidow O. Successful voriconazole treatment of disseminated Fusarium infection in an immunocompromized patient. Clin Infect Dis 2003;37:311–3.
  • Clancy CJ, Nguyen MH. In vitro efficacy and fungicidal activity of voriconazole against Aspergillus and Fusarium species. J Clin Microbiol Infect Dis 1998;17:573–5.
  • Paphitou NI, Ostrosky-Zeichner L, Paetznick VL, Rodriguez JR, Chen E, Rex JR. In vitro activities of investigational triazoles against Fusarium species: effects on inoculum size and incubation time on broth microdilution susceptibility test results. Antimicrob Agents Chemother 2002;46:3298–300.
  • Lionakis MS, Lewis RE, Samonis G, Kontoyiannis DP. Pentamidine is active in vitro against Fusarium species. Antimicrob Agents Chemother 2003;47:3252–9.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.